Recruitment Communication Methods for Type 1 Diabetes Screening
(FIND T1D Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this clinical trial is to understand how many individuals who previously participated in the Indiana Biobank will return a type 1 diabetes home screening kit based upon different methods of recruitment communication. The main question it aims to answer is:
What form of recruitment communication is most effective for completing a type 1diabetes home screening kit?
Researchers will compare two types of recruitment contact: email and mail based communication (low-touch) versus phone contact and follow-up by a research team member (high-touch).
Participants will be contacted either via email/mail or by phone and asked if they want to complete a type 1 diabetes home screening kit.
Are You a Good Fit for This Trial?
This trial is for adults who previously took part in the Indiana Biobank, including both healthy individuals and those with type 1 diabetes. There are no specific inclusion or exclusion criteria listed.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Recruitment Communication
Participants are contacted via email/mail or phone to complete a type 1 diabetes home screening kit
Follow-up
Participants are monitored for the return of home screening kits and consent rates
What Are the Treatments Tested in This Trial?
Trial Overview
The study compares two ways of inviting people to complete a home screening kit for type 1 diabetes: one group gets emails or mail, while the other receives phone calls and follow-up from researchers. The goal is to see which method works better.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
Indiana University
Lead Sponsor
Sanofi
Industry Sponsor
Paul Hudson
Sanofi
Chief Executive Officer since 2019
Degree in Economics from Manchester Metropolitan University
Christopher Corsico
Sanofi
Chief Medical Officer
MD from Cornell University, MPH in Chronic Disease Epidemiology from Yale University
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.